60 related articles for article (PubMed ID: 20437461)
21. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model.
Jeong EJ; Lin H; Hu M
J Pharmacol Exp Ther; 2004 Jul; 310(1):376-85. PubMed ID: 15020665
[TBL] [Abstract][Full Text] [Related]
22. [Physiology of the tracheal epithelium].
Durand J
Arch Int Physiol Biochim; 1988 Sep; 96(4):A347-62. PubMed ID: 2463815
[TBL] [Abstract][Full Text] [Related]
23. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
24. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories.
Hayeshi R; Hilgendorf C; Artursson P; Augustijns P; Brodin B; Dehertogh P; Fisher K; Fossati L; Hovenkamp E; Korjamo T; Masungi C; Maubon N; Mols R; Müllertz A; Mönkkönen J; O'Driscoll C; Oppers-Tiemissen HM; Ragnarsson EG; Rooseboom M; Ungell AL
Eur J Pharm Sci; 2008 Dec; 35(5):383-96. PubMed ID: 18782614
[TBL] [Abstract][Full Text] [Related]
25. Distinct transport characteristics of basolateral peptide transporters between MDCK and Caco-2 cells.
Sawada K; Terada T; Saito H; Inui K
Pflugers Arch; 2001 Oct; 443(1):31-7. PubMed ID: 11692263
[TBL] [Abstract][Full Text] [Related]
26. Development of an in silico model for predicting efflux substrates in Caco-2 cells.
Zhang L; Balimane PV; Johnson SR; Chong S
Int J Pharm; 2007 Oct; 343(1-2):98-105. PubMed ID: 17583455
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic interplay of phase II metabolism and transport: a theoretical study.
Wu B
J Pharm Sci; 2012 Jan; 101(1):381-93. PubMed ID: 21905031
[TBL] [Abstract][Full Text] [Related]
28. The Caco-2 cell monolayer: usefulness and limitations.
Sun H; Chow EC; Liu S; Du Y; Pang KS
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):395-411. PubMed ID: 18433344
[TBL] [Abstract][Full Text] [Related]
29. Absorption, Conjugation and Efflux of the Flavonoids, Kaempferol and Galangin, Using the Intestinal CACO-2/TC7 Cell Model.
Barrington R; Williamson G; Bennett RN; Davis BD; Brodbelt JS; Kroon PA
J Funct Foods; 2009 Jan; 1(1):74-87. PubMed ID: 20046888
[TBL] [Abstract][Full Text] [Related]
30. Metabolite to parent drug concentration ratio as a function of parent drug extraction ratio: cases of nonportal route of administration.
Lane EA; Levy RH
J Pharmacokinet Biopharm; 1981 Aug; 9(4):489-96. PubMed ID: 7310646
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Profiles of Extracellular MicroRNA Secreted by Caco-2 Cells from the Apical Side of the Membrane under Static and Microcirculation Conditions.
Nikulin SV; Gerasimenko TN; Shilin SA; Gazizov IN; Kindeeva OV; Sakharov DA
Bull Exp Biol Med; 2019 Mar; 166(5):626-630. PubMed ID: 30903497
[TBL] [Abstract][Full Text] [Related]
32. Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability.
Nguyen TT; Duong VA; Maeng HJ
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371794
[TBL] [Abstract][Full Text] [Related]
33. Simplified Method to Determine the Efflux Ratio on P-Glycoprotein Substrates Using Three-Compartment Model Analysis for Caco-2 Cell Assay Data.
Nagayasu M; Ozeki K; Sakurai Y; Tsutsui H; Onoue S
Pharm Res; 2019 Dec; 37(1):13. PubMed ID: 31873817
[TBL] [Abstract][Full Text] [Related]
34. Modeling and Simulation of Intracellular Drug Transport and Disposition Pathways with Virtual Cell.
Baik J; Rosania GR
J Pharm Pharmacol (Los Angel); 2013 Sep; 1(1):. PubMed ID: 24364041
[TBL] [Abstract][Full Text] [Related]
35. The importance of villous physiology and morphology in mechanistic physiologically-based pharmacokinetic models.
Chen EP; Tai G; Ellens H
Pharm Res; 2014 Feb; 31(2):305-21. PubMed ID: 23990312
[TBL] [Abstract][Full Text] [Related]
36. Compartmental models for apical efflux by P-glycoprotein: part 2--a theoretical study on transporter kinetic parameters.
Korzekwa K; Nagar S
Pharm Res; 2014 Feb; 31(2):335-46. PubMed ID: 23959852
[TBL] [Abstract][Full Text] [Related]
37. Interplay of transporters and enzymes in the Caco-2 cell monolayer: I. effect of altered apical secretion.
Fan J; Maeng HJ; Pang KS
Biopharm Drug Dispos; 2010 May; 31(4):215-27. PubMed ID: 20437461
[TBL] [Abstract][Full Text] [Related]
38. Interplay of transporters and enzymes in drug and metabolite processing.
Pang KS; Maeng HJ; Fan J
Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
[TBL] [Abstract][Full Text] [Related]
39. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study.
Sun H; Pang KS
Drug Metab Dispos; 2008 Jan; 36(1):102-23. PubMed ID: 17932224
[TBL] [Abstract][Full Text] [Related]
40. Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis.
Tam D; Sun H; Pang KS
Drug Metab Dispos; 2003 Oct; 31(10):1214-26. PubMed ID: 12975330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
